Twist Bioscience's market cap is currently $2.79B. The company's EPS TTM is $-3.384; its P/E ratio is ―; Twist Bioscience is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 312.97M	$ 245.11M	$ 203.56M	$ 132.33M	$ 90.10M
Gross Profit	$ 133.35M	$ 89.73M	$ 84.23M	$ 51.71M	$ 28.69M
Operating Income	$ -220.83M	$ -217.16M	$ -249.02M	$ -153.26M	$ -117.58M
EBITDA	$ -176.71M	$ -174.15M	$ -191.55M	$ -143.91M	$ -132.09M
Net Income	$ -208.73M	$ -204.62M	$ -217.86M	$ -152.10M	$ -139.93M
Balance Sheet
Cash & Short-Term Investments	$ 276.40M	$ 336.41M	$ 504.97M	$ 477.86M	$ 290.00M
Total Assets	$ 614.32M	$ 776.40M	$ 961.38M	$ 702.10M	$ 398.88M
Total Debt	$ 85.03M	$ 94.07M	$ 94.91M	$ 62.92M	$ 35.98M
Net Debt	$ -141.29M	$ -192.40M	$ -283.77M	$ -402.91M	$ -57.69M
Total Liabilities	$ 141.63M	$ 152.97M	$ 171.99M	$ 121.28M	$ 62.62M
Stockholders' Equity	$ 472.69M	$ 623.43M	$ 789.38M	$ 580.82M	$ 336.26M
Cash Flow
Free Cash Flow	$ -69.17M	$ -170.25M	$ -226.24M	$ -139.31M	$ -152.12M
Operating Cash Flow	$ -64.09M	$ -142.47M	$ -124.39M	$ -112.24M	$ -142.25M
Investing Cash Flow	$ -3.07M	$ 50.61M	$ -232.93M	$ 156.16M	$ -114.65M
Financing Cash Flow	$ 6.89M	$ 911.00K	$ 270.53M	$ 329.18M	$ 303.73M

Currency in USD

Twist Bioscience Earnings and Revenue History

Income Statement >

Twist Bioscience Debt to Assets

Balance Sheet >

Twist Bioscience Cash Flow

Cash Flow >

Twist Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing